Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, May 1998, p. 1181-1186, Vol. 42, No. 5
Department of Microbiology,
Received 9 October 1997/Returned for modification 15 January
1998/Accepted 9 March 1998
Escherichia coli TUM1083, which is resistant to
ampicillin, carbenicillin, cephaloridine, cephalothin, piperacillin,
cefuzonam, and aztreonam while being sensitive to cefoxitin,
moxalactam, cefmetazole, ceftazidime, and imipenem, was isolated from
the urine of a patient treated with
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Cloning and Sequencing of the Gene Encoding Toho-2, a Class A
-Lactamase Preferentially Inhibited by Tazobactam
-lactam antibiotics. The
-lactamase (Toho-2) purified from the bacteria hydrolyzed
-lactam
antibiotics such as penicillin G, carbenicillin, cephaloridine,
cefoxitin, cefotaxime, ceftazidime, and aztreonam and especially had
increased relative hydrolysis rates for cephalothin, cephaloridine,
cefotaxime, and ceftizoxime. Different from other extended-spectrum
-lactamases, Toho-2 was inhibited 16-fold better by the
-lactamase inhibitor tazobactam than by clavulanic acid. Resistance
to
-lactams was transferred by conjugation from E. coli
TUM1083 to E. coli ML4909, and the transferred plasmid was
about 54.4 kbp, belonging to the incompatibility group IncFII. The
cefotaxime resistance gene for Toho-2 was subcloned from the 54.4-kbp
plasmid. The sequence of the gene was determined, and the open reading
frame of the gene was found to consist of 981 bases. The nucleotide
sequence of the gene (DDBJ accession no. D89862) designated as
blatoho was found to have 76.3% identity to
class A
-lactamase CTX-M-2 and 76.2% identity to Toho-1. It has
55.9% identity to SHV-1
-lactamase and 47.5% identity to TEM-1
-lactamase. Therefore, the newly isolated
-lactamase designated
as Toho-2 produced by E. coli TUM1083 is categorized as an
enzyme similar to Toho-1 group
-lactamases rather than to mutants of
TEM or SHV enzymes. According to the amino acid sequence deduced from
the DNA sequence, the precursor consisted of 327 amino acid residues.
Comparison of Toho-2 with other
-lactamase (non-Toho-1 group)
suggests that the substitutions of threonine for Arg-244 and arginine
for Asn-276 are important for the extension of the substrate
specificity.
*
Corresponding author. Mailing address: Department of
Microbiology, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, Tokyo 1438540, Japan. Phone: 81-3-3762-4151. Fax:
81-3-5493-5415. E-mail:
yoishii{at}sirius.med.toho-u.ac.jp.
Antimicrobial Agents and Chemotherapy, May 1998, p. 1181-1186, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |